[HTML][HTML] Peptide-drug conjugates and their targets in advanced cancer therapies
P Hoppenz, S Els-Heindl, AG Beck-Sickinger - Frontiers in chemistry, 2020 - frontiersin.org
Cancer became recently the leading cause of death in industrialized countries. Even though
standard treatments achieve significant effects in growth inhibition and tumor elimination …
standard treatments achieve significant effects in growth inhibition and tumor elimination …
[HTML][HTML] Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
S Kloock, CG Ziegler, U Dischinger - Pharmacology & Therapeutics, 2023 - Elsevier
Obesity and its comorbidities, including type 2 diabetes mellitus, cardiovascular disease,
heart failure and non-alcoholic liver disease are a major health and economic burden with …
heart failure and non-alcoholic liver disease are a major health and economic burden with …
[HTML][HTML] Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers
JA Borovac, D D'Amario, J Bozic… - World journal of …, 2020 - ncbi.nlm.nih.gov
Heart failure (HF) is a complex clinical syndrome characterized by the activation of at least
several neurohumoral pathways that have a common role in maintaining cardiac output and …
several neurohumoral pathways that have a common role in maintaining cardiac output and …
[HTML][HTML] Bisphenol A (BPA) leading to obesity and cardiovascular complications: a compilation of current in vivo study
BPA is one of the most common endocrine disruptors that is widely being manufactured
daily nationwide. Although scientific evidence supports claims of negative effects of BPA on …
daily nationwide. Although scientific evidence supports claims of negative effects of BPA on …
Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block
H Suryawanshi, R Clancy, P Morozov… - Cardiovascular …, 2020 - academic.oup.com
Aims Investigating human heart development and applying this to deviations resulting in
disease is incomplete without molecular characterization of the cell types required for …
disease is incomplete without molecular characterization of the cell types required for …
The role of the autonomic nervous system in cardiac arrhythmias: the neuro-cardiac axis, more foe than friend?
AA Manolis, TA Manolis, EJ Apostolopoulos… - Trends in cardiovascular …, 2021 - Elsevier
The autonomic nervous system (ANS) with its two limbs, the sympathetic (SNS) and
parasympathetic nervous system (PSNS), plays a critical role in the modulation of cardiac …
parasympathetic nervous system (PSNS), plays a critical role in the modulation of cardiac …
[HTML][HTML] based sensors for rapid important biomarkers detection
Paper-based sensors have received increasing attention in the last decade, their use has
spread to various application fields, such as clinical diagnostic, food safety, environmental …
spread to various application fields, such as clinical diagnostic, food safety, environmental …
Physiological and therapeutic roles of neuropeptide Y on biological functions
P Shende, D Desai - Cell Biology and Translational Medicine, Volume 7 …, 2020 - Springer
Neuropeptide Y (NPY), an amino acid, used for various physiological processes for
management and treatment of various ailments related to central nervous system …
management and treatment of various ailments related to central nervous system …
Signaling and function of cardiac autonomic nervous system receptors: Insights from the GPCR signalling universe
A Lymperopoulos, N Cora, J Maning, AR Brill… - The FEBS …, 2021 - Wiley Online Library
The two branches of the autonomic nervous system (ANS), adrenergic and cholinergic, exert
a multitude of effects on the human myocardium thanks to the activation of distinct G protein …
a multitude of effects on the human myocardium thanks to the activation of distinct G protein …
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade
Aims ST-elevation myocardial infarction is associated with high levels of cardiac sympathetic
drive and release of the co-transmitter neuropeptide Y (NPY). We hypothesized that despite …
drive and release of the co-transmitter neuropeptide Y (NPY). We hypothesized that despite …